1. Endonasal Dacryocystorhinostomy for Nasolacrimal Duct Obstruction in Patients with Sarcoidosis
- Author
-
Inbal Avisar, Raman Malhotra, Peter J. Dolman, Jean-Louis deSousa, Bhupendra C. Patel, Alan A McNab, and Dinesh Selva
- Subjects
Adult ,Male ,medicine.medical_specialty ,Sarcoidosis ,medicine.medical_treatment ,Dacryocystorhinostomy ,Mucous membrane of nose ,Nasal congestion ,Lacrimal Duct Obstruction ,medicine ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,Nasolacrimal duct ,business.industry ,Retrospective cohort study ,Middle Aged ,medicine.disease ,eye diseases ,Lacrimal sac ,Surgery ,Ophthalmology ,Treatment Outcome ,medicine.anatomical_structure ,Nasolacrimal duct obstruction ,Female ,sense organs ,medicine.symptom ,business ,Nasolacrimal Duct - Abstract
To evaluate the outcomes of endonasal dacryocystorhinostomy (EN-DCR) surgery in patients with sarcoidosis.Retrospective chart review of all patients with sarcoidosis undergoing EN-DCR in 6 practices from 1999-2011.We included 18 procedures in 14 patients (8 female, 6 male) who underwent EN-DCR for acquired NLDO secondary to sarcoidosis. The mean age was 53.7 (range 38-82). The presenting symptom in all cases was epiphora. Eight patients (57%) complained of having additional nasal congestion. Surgery was performed using endoscopic powered-type DCR with flaps in 12/18 (67%) and non-endoscopic mechanical EN-DCR in 6/18 (33%). In 15 (83%) cases the lacrimal sac and nasal mucosa appeared abnormally yellowish, crusty, oedematous and friable. Five patients were treated with pre-operative oral steroid and overall 8 patients had oral prednisolone post operatively, 30-60 mg tapered within 10 days-8 weeks. One patient had difficulties in tapering down the oral steroids at 6 months of follow-up. All patients were free of epiphora and patent to syringing, with nasal endoscopy revealing free flow of fluorescein through the ostium at a mean follow-up of 11.3 months (median follow-up 9 months).All 18 cases of acquired nasolacrimal duct obstruction secondary to sarcoidosis were treated successfully with EN-DCR. An abnormal appearance of the nasal mucosa is an important sign. Nasal congestion is a frequent sign. A successful outcome may not depend on intensive long-term therapy with local or systemic steroids. Mechanical or powered EN-DCR for nasolacrimal duct obstruction secondary to sarcoidosis achieves encouraging medium-term outcomes.
- Published
- 2013
- Full Text
- View/download PDF